Skip to content
healthcare.dev

TECELRA

NDC 83205-0001, afamitresgene autoleucel, injection, suspension, from USWM CT, LLC.

Product NDC
83205-0001
Status
Listed
Labeler
USWM CT, LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125789
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83205-0001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AFAMITRESGENE AUTOLEUCEL10000000000 1/1
Package NDCNDC-11Package
83205-0001-2832050001021 INJECTION, SUSPENSION in 1 BAG (83205-0001-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83205-0001

Use it

Look up 83205-0001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83205-0001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83205-0001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.